Here we highlight a subset of our preferred stocks from the screener. Overview: Flowtech Fluidpower plc, with a market cap of £38.23 million, distributes engineering components and assemblies ...
Protagonist Therapeutics reported a clean Phase 3 win on Monday for rusfertide — its rare blood disorder therapy — putting it on track for a fourth-quarter FDA … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results